Abstract:Background Diffusion-weighted (DW) imaging has shown potential to differentiate between malignant and benign breast lesions. However, different b values have been used with varied sensitivity and specificity. This study aims to prospectively evaluate the influence of b value on the detection and assessment of breast lesions. Methods Institutional review board approval and informed patient consent were obtained. Between February 2010 and September 2010, sixty women suspected of having breast cancer by clinical examination and mammography underwent bilateral breast MRI and DW imaging (with maximum b values of 600, 800, and 1000 s/mm 2 ). Conspicuity grades of lesions at different b values on DW images were performed. Signal intensity and apparent diffusion coefficient (ADC) values were recorded and compared among different b values by the signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR) and receiver operating characteristic (ROC) curve. Results Fifty-seven lesions from 52 recruited patients including 39/57 (68%) malignant and 18/57 (32%) benign were confirmed with pathology. DCE MRI accurately detected 53 lesions with the sensitivity of 93.0% and specificity of 66.7%, and DW imaging accurately detected 51 lesions with the sensitivity of 89.5% and specificity of 100%. There were no significant differences in conspicuity grades compared among the three b values ( P = 0.072), although the SNR and CNR of breast lesions decreased significantly with higher b values. Mean ADCs of malignant lesions (b = 600 s/mm 2 , 1.07 ± 0.26 × 10 -3 mm 2 /s; b = 800 s/mm 2 , 0.96 ± 0.22 × 10 -3 mm 2 /s; b = 1000 s/mm 2 , 0.92 ± 0.26 × 10 -3 mm 2 /s) were significantly lower than those of benign lesions (b = 600 s/mm 2 , 1.55 ± 0.40 × 10 -3 mm 2 /s; b = 800 s/mm 2 , 1.43 ± 0.38 × 10 -3 mm 2 /s; b = 1000 s/mm 2 , 1.49 ± 0.38 × 10 -3 mm 2 /s) with all P values <0.001, but there were no significant differences among the three b values ( P = 0.303 and 0.840 for malignant and benign lesions, respectively). According to the area under the ROC curves, which were derived from ADC and differentiate malignant from benign lesions, no significant differences were found among the three b values ( P = 0.743). Conclusions DW imaging is a potential adjunct to conventional MRI in the differentiation between malignant and benign breast lesions. Varying the maximum b value from 600 to 1000 s/mm 2 does not influence the conspicuity of breast lesions on DW imaging at 1.5 T.

Ultra-High b-Value Diffusion-Weighted Imaging-Based Abbreviated Protocols for Breast Cancer Detection

Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI

Progresses of MRI diagnosis in breast cancer

Breast lesion morphology assessment with high and standard b values in diffusion-weighted imaging at 3 Tesla

Optimizing Image Quality with High-Resolution, Deep-Learning-Based Diffusion-Weighted Imaging in Breast Cancer Patients at 1.5 T

Threshold Isocontouring on High B-Value Diffusion-Weighted Images in Magnetic Resonance Mammography.

Performance of Diffusion-weighted Imaging-based Noncontrast MRI Protocols for Diagnosis of Breast Cancer: A Systematic Review and Meta-Analysis

Standardization and advancements efforts in breast diffusion-weighted imaging

Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) in detection and characterization of neoplastic breast lesions

Conspicuity of Breast Lesions at Different B Values on Diffusion-Weighted Imaging

Screening Breast MRI Primer: Indications, Current Protocols, and Emerging Techniques

Use of Diffusion Kurtosis Imaging and Quantitative Dynamic Contrast-Enhanced MRI for the Differentiation of Breast Tumors

Application of quantitative evaluation of computed diffusion-weighted imaging using 3-T magnetic reso-nance imaging for breast cancer

Multiple parameters from ultrafast dynamic contrast-enhanced magnetic resonance imaging to discriminate between benign and malignant breast lesions: Comparison with apparent diffusion coefficient

Usefulness of Combined Advanced Dynamic Contrast-Enhanced and Diffusion-Weighted MRI Over Ultrasonography in Differentiating Cancer From Benign Lesions in Dense Breasts

Differential diagnosis of benign and malignant breast masses using diffusion-weighted magnetic resonance imaging

Evaluation of apparent diffuse coefficient (ADC) with regards to reproducibility and diagnostic accuracy as well as possible significance of pre - and post - contrast acquisition and employment of different b values

Performance of DWI As a Rapid Unenhanced Technique for Detecting Mammographically Occult Breast Cancer in Elevated-Risk Women with Dense Breasts.

The role of diffusion weighted imaging as supplement to dynamic contrast enhanced breast MRI: Can it help predict malignancy, histologic grade and recurrence?

Diffusion‐weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer

MR Diffusion Weighted Imaging with Background Signal Suppression in Breast Cancer